Locking a biochemical gate that admits fuel into immune-suppressing cells could slow tumor progression and assist the treatment of multiple cancers, says new research from the Wistar Institute,
Before being tested in animals or humans, most cancer drugs are evaluated in tumor cells grown in a lab dish. However, in recent years, there has been a
Simple blood test can spot if breast cancer will return up to TWO YEARS earlier than current scans, finds study Looks for markers of mutant DNA released from
Bloating can be a sign of ovarian cancer Everyone has flatulence. Sometimes more, sometimes less. It depends on how we digest and what we have eaten. However, certain
Researchers from Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania analyzed the largest cohort to date of pediatric patients with
Just one year ago, Jamil Rivers, 40, found out she had metastatic breast cancer. The Philadelphia mom of three, who is still working full-time, tells PEOPLE about her
Routinely vaccinating 12 to 13 year old girls against HPV has slashed rates of cervical disease by nearly 90% All girls in the UK have been offered the
A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England. The National Institute for Health and Care Excellence
A student at the University of California, Riverside, presented research results at the annual meeting of the American Association for Cancer Research, or AACR, in Atlanta showing that
Maintenance treatment with the PARP inhibitor rucaparib (Rubraca) was well tolerated and provided clinical responses among patients with advanced BRCA- or PALB2-mutated pancreatic cancer sensitive to platinum-based chemotherapy,
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok